Shilpa Medicare Q4 Results
- BSE: 530549
- NSE: SHILPAMED
- ISIN: INE790G01031
- Sector: Biotechnology & Drugs
BSE
435.00
-6.80 (-1.54%)
-6.80 (-1.54%)Volume23.78 K
Updated: Fri 8 May, 2026 | 15:29:20
NSE
434.00-7.70 (-1.74%)
-7.70 (-1.74%)Volume6.92 L
Updated: Fri 8 May, 2026 | 15:29:57
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Shilpa Medicare Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 310.91 | 338.65 | 16.26% | 242.13 | 28.41% |
| Depreciation/ Amortization | 28.79 | 30.36 | -0.06% | 26.63 | 8.14% |
| Operating Income | 19.88 | 71.07 | -61.68% | 49.84 | -60.11% |
| Net Income | 14.51 | 44.58 | -54.35% | 24.50 | -40.79% |
| Other Operating Expenses Total | 78.64 | 78.65 | 6.08% | 58.11 | 35.33% |
| Net Income Before Taxes | 15.27 | 60.85 | -63.29% | 27.71 | -44.89% |
| Total Revenue | 330.79 | 409.73 | 3.59% | 291.97 | 13.30% |
| Selling/ General/ Admin Expenses Total | 70.93 | 83.45 | -3.49% | 66.45 | 6.74% |
| Diluted Normalized EPS | 2.11 | 2.86 | 29.86% | 1.10 | 92.50% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.